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Hip osteoarthritis (OA) is characterized by cartilage degradation, subchondral bone sclerosis and
osteophyte formation. Nowadays, OA is thought to develop via different etiologies that all lead to a
similar form of end stage joint degradation. One of these subtypes is related to an abnormal shaped hip
joint, like acetabular dysplasia and a cam deformity. These bony abnormalities are highly predictive for
development of hip OA, but they are likely to already be present from childhood. This suggests that these
deformations induce OA changes in the hip, well before extensive hip degradation becomes present three
to four decades later. Accurate detection and successful characterization of these early OA events might
lead to better treatment options for hip OA besides nowadays available invasive joint replacement sur-
gery. However, current diagnostic imaging techniques like radiographs or plain magnetic resonance
imaging (MRI), are not sensitive enough to detect these subtle early OA changes. Nor are they able to
disentangle intertwined and overlapping cascades from different OA subtypes, and neither can they
predict OA progression. New and more sensitive imaging techniques might enable us to detect ﬁrst OA
changes on a cellular level, providing us with new opportunities for early intervention. In this respect,
shape analysis using radiography, MRI, computed tomography (CT), single photon emission computed
tomography (SPECT)/CT, and positron emission tomography (PET) might prove promising techniques and
be more suited to detect early pathological changes in the hip joint. A broad application of these tech-
niques might give us more understanding what can be considered physiological adaptation of the hip, or
when early OA really starts. With a more clear deﬁnition of early OA, more homogenous patient pop-
ulations can be selected and help with the development of new disease modifying OA interventions.
© 2014 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.Introduction
At present, osteoarthritis (OA) is the most prevalent arthritic
disease in the USA1,2. Hip OA is rare below the age of 45 years and
the prevalence increases substantially afterwards, with a peak
incidence around the age 75 years1. The incidence of OA is expected
to rise due to the increasingly ageing population and by 2030, a
quarter of the United States adult population is expected to be
diagnosed with arthritis3. Therapeutic results from physical ther-
apy and weight-loss are rather modest4. Therefore, invasive joint
replacement surgery currently remains the only available treat-
ment option. With further increasing patient numbers, direct: H. Weinans, UMC Utrecht,
HP-G.05.228, PO Box 85500,
6481.
einans).
ternational. Published by Elsevier Lmedical and lost productivity costs of OA will increase5. In order to
limit patient and societal burden, researchers aim to prevent or
reverse OA.
The main feature of OA is progressive cartilage degradation6,
though pathologic changes in other tissues within the articular
joint characterize OA as ‘a whole joint disease’. Many complex
interactions have been described between different cells and tis-
sues of the articular joint7e9, but we still have no clear concept
how these different aspects intertwine and eventually lead to OA.
This may be explained due to the fact that OA should be consid-
ered a group of overlapping etiologies10,11, and probably a different
cascade of events exists for each subtype of OA. Due to over-
lapping cascades from different OA subtypes, it is difﬁcult to
generate a clear map that explains OA pathology and predicts its
future progression. Without proper selection of a homogenous
patient population that all share similar disease aetiology, the
evaluation of surgical procedures and the quest for new disease
modifying OA drugs (DMOADs) is rather complicated. This may betd. All rights reserved.
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successfully.
OA patients are diagnosed using weight bearing plain radio-
graphs12 and magnetic resonance imaging (MRI)13. These imaging
techniques are not designated to unravel the complex and inter-
twined interactions between different cells and tissues of the OA
joint, and using these techniques, it may be impossible to differ-
entiate the different subtypes of OA. More comprehensive patient
studies using multi-modality imaging seem a prerequisite for the
next breakthrough in OA research. This review on hip OA will
discuss: (1) development of hip OA and early pathophysiological
changes in different hip joint tissues, (2) what current and new
imaging preferred techniques are most likely to enhance our
knowledge on OA, and (3) what should be considered risk factors or
predisposing aspects of hip OA, or when do we call it early OA?
Shape induced OA and early pathological joint tissue changes
As mentioned in the Introduction, OA is likely to develop due to
different pathophysiological pathways that all lead to the same
disease presentation. This idea is especially supported for devel-
opment of hip OA, since female gender14 and obesity15,16 are only
modestly associatedwith hip OA, which is in sharp contrast to OA in
other articular joints. A suspected subtype of hip OA is related to an
abnormal shape of the hip joint. Already in 1939, Wiberg described
acetabular dysplasia as a cause for OA17. Especially when patients
suffer from severe subluxation of the hip joint, early degeneration
is likely to develop due to mechanical instability18. Also an incon-
gruent hip joint, either resulting from Perthes' disease or slipped
capital femoral epiphysis with subsequent femoral head malfor-
mation, poses a high risk for early development of hip OA19,20.Fig. 1. Mechanism of FAI. Hip joints with a normal, spherical femoral head (A), a cam defor
range of motion (D). A cam deformity is forced into the acetabulum (cam impingement) dur
arrowhead) (E). With pincer impingement an abnormal contact between the femoral neck a
(red arrowheads) (F). Not every cam or pincer deformity will result in impingement, only thBesides these well known gross malformations, it has become
clear that more subtle shape abnormalities also play an important
role in hip OA. Recent prospective cohort studies showed that even
a slight under coverage of the femoral head (a form of mild
dysplasia) can confer an ~6 fold increased risk for development of
hip OA21e23. In contrast to under coverage, femoral coverage can
become abnormally high due to acetabular protrusion and retro-
version, which results in a pincer type of femoroacetabular
impingement (FAI) [Fig. 1(B)]. Especially during ﬂexion/abduction,
patients suffer from impingement complaints [Fig. 1(E)]. Another
type of FAI is caused by an extra bone formation at the anterolateral
headeneck junction, which is called a cam deformity [Fig.1(C)]. The
prevalence of this type of deformity is signiﬁcantly higher in
(young) male athletes participating in high impact sports (89%) as
compared with their non-athletic peers (9%) [Fig. 2]24,25. A group of
adolescent soccer players were prospectively followed for 2.5 years
and 70% gradually developed a cam deformity of which 1/3 had a
severe cam. Examination by plain radiography showed that a cam
deformity especially developed during skeletal growth, whereas
the shape of the proximal femur remains stable after growth plate
closure [Fig. 2]. This suggests that frequent and high impact joint
loading (over) stimulates growth plate cells and induces additional
bone formation in the anterolateral neck region, which may hinder
joint functioning later in life. Clinically, patients with a cam
deformity especially suffer from impingement complaints during
ﬂexion and internal rotation of the hip, when the cam deformity is
forced into the acetabulum [Fig. 1(F)]. This abnormal contact might
results in labral tears, damage to femoral cartilage, and detachment
of the acetabular cartilage. Acetabular cartilage especially detaches
from subchondral bone at the location where the cam deformity
enters the acetabulum26. As a result of repetitive impingement, amity (B), and a pincer deformity (C). A spherical head provides the hip a physiological
ing ﬂexion and internal rotation leading to delamination of the acetabular cartilage(red
nd acetabular rim results during ﬂexion causing labral damage and a contrecoup lesion
ose patients with repetitive impingement events are likely to suffer soft tissue damage.
Fig. 2. Development of a cam deformity during growth. The development of a hip joint as seen on frog-leg lateral radiographs (with the corresponding anterior posterior (AP) pelvic
view in the left upper corner). Normal development of a hip with an open growth plate (left) resulting in a spherical femoral head (middle) which remained spherical after 2.5 years
follow-up (right). Abnormal development of a hip with an open growth plate showing a slight ﬂattening of the head neck junction (left), which evolved into a cam deformity during
skeletal growth (middle) but did not change after closure of the growth plate (right, at 2.5 years follow-up).
M. Siebelt et al. / Osteoarthritis and Cartilage 22 (2014) 1470e14801472cam deformity has been found to strongly predict OA and
(dependent on the size of the cam deformity) results in a 4- to 10-
fold increased risk for development of hip OA27. Although these
studies have underlined the formation of a cam deformity and the
relation of abnormal hip shape to hip OA, the period in between
cam development and when hip OA becomes radiographically
identiﬁable is also characterized by marked tissue changes.
The normal congruent hip joint is composed of different cell
types and tissues that all together facilitate hip motion [Fig. 1(A),
(D)]. Normally in healthy cartilage, chondrocytes produce sulph-
ated glycosaminoglycans (sGAG) that contain negatively charged
sulphate groups which confers a negative ﬁxed charged density
(FCD). Due to the FCD, cations and water are drawn into the carti-
lage, which generates a high hydrostatic pressure within the extra-
cellular matrix (ECM). This speciﬁc feature allows cartilage to
‘absorb’ compressive forces as a consequence of locomotion28,29
and dissipate these forces through the subchondral cortical plate
and trabecular bone. Therefore, cartilage sGAG content is consid-
ered an indicator of cartilage health30. Normal hip shape deﬁned by
a spherical femoral head together with optimal femoral coverage
by the acetabulum, results in normal and evenly distributed contact
stresses within the hip. However, in hip joints with an abnormal
morphology like cam deformity and dysplasia, high peak stresses
develop within the anterosuperior acetabular cartilage31.
This biomechanically induced high stress state triggers cartilage
and bone to undergo pathophysiological changes ultimately lead-
ing to hip OA. Chondrocytes are sensitive to mechanical stimuli and
when exposed to high-peak forces, they can start to produce cy-
tokines and enzymes that can degrade cartilage ECM32. Chronic
cartilage loading through strenuous running induces clear cartilage
sGAG loss33 which is thought to result from pathological chon-
drocyte stress responses34. A loss of sGAG is considered one of the
earliest hallmarks of OA, which happens well before OA is detected
radiographically35,36. sGAG loss changes biomechanical properties
of articular cartilage37, and subsequent changed force propagation
through the subchondral bone may induce bone adaptation38.
Enhanced bone remodelling is a well known feature of (early) OA
development and is thought to result from increased osteoclast
activity39e41, followed by an increase in osteoblast activity which
induces sclerotic thickening of the subchondral plate. This has alsobeen found in hips with a cam deformity, that show a higher bone
mineral density (BMD) than hips without a cam deformity and
BMD also relates to the severity of hip deformation42.
In conclusion, from the development to the eventual end stage
hip OA, there are many changes that can be considered a hallmark
of early OA. Imaging techniques capable of capturing these changes
in a quantitative manner would allow for more enhanced screening
of developing hip OA. The question remains however, whether
valid imaging techniques are capable to capture these changes
related to the onset of hip OA.
Imaging of early hip OA
Plain radiography
In progressive stages of the disease, hip OA can be clearly
assessed by weight-bearing radiographs, which allow for excellent
imaging of dense tissues to evaluate joint space narrowing (JSN)
and bone related changes that are associated with the disease (like
osteophyte formation, cysts and sclerosis). While measurement of
JSN from radiographs is still the only food and drug administration
(FDA) approved outcome measure of OA, it is not sensitive enough
to detect OA at an early stage. However, by the recognition of above
mentioned bony morphological risk factors, radiographs might be
useful in the prediction of OA. Cam deformities can be visualized as
a non-sphericity of the femoral head on radiographs and preferably
at least two radiographic views are needed to avoid misclassiﬁca-
tion. The currently most used measure to quantify a cam deformity
is the alpha angle [Fig. 3], which measures the extent to which the
femoral head deviates from being spherical. As greater alpha angles
(larger cam deformities) confer a higher risk for development of hip
OA, validated alpha angle threshold values of 78 for a pathological
cam deformity and 60 for the presence of a cam deformity have
been proposed43. Mild acetabular dysplasia is usually quantiﬁed by
a centre edge angle lower than 20 or 30 and AP pelvic radiographs
together with a lateral view provides the best prediction for OA21.
There are indications that other shape aspects of the hip might also
be associated with hip OA. These shape aspects have been identi-
ﬁed by statistical shape model (SSM), which is a technique able to
quantify all variation in shape within a given population. In short, a
Fig. 3. The alpha angle as measured on AP radiographs (AeC). The best ﬁtting circle is drawn around the femoral head and then a line from the centre of the head through the centre
of the neck. From the centre of the head, a second line is drawn to the point where the superior surface of the headeneck junction ﬁrst departs from the circle. The angle between
these two lines is the alpha angle, resulting in values <60 in hips with a spherical femoral head (A); a cam deformity is deﬁned by an alpha angle >60 (B); and a pathological cam
deformity by an alpha angle >78 (C). The point set of a shape model is shown in (D), where the shape of the hip is deﬁned by a set of points which are always positioned on the
same anatomical landmark.
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bone is created and applied to all hips of interest. Then, principal
component analysis is used to transfer the set of points into a SSM.
An SSM consists of a number of shape variants (modes) that
together describe the total variation in hip shape. Shape aspects
which are correlated are captured in one mode such that each
single mode represents independent shape variants. Each inde-
pendent shape variant is quantitatively described as the mean,
which corresponds with 0, and the positive or negative deviation
from the mean as expressed in the number of standard deviations
(SDs). This statistical approach to describe the shape of the hip
allows to study the association between hip shape and OA without
a predeﬁned hypothesis44. In addition to above mentioned
acetabular dysplasia and a cam deformity, a short and broad
femoral neck have been identiﬁed as possible predictive shape
variants using SSM. Although the shape variants as quantiﬁed by
SSM are reproducible45,46, different studies use different shape
models with different landmark points along the contour, making
result difﬁcult to compare and interpret. Hence, the validity of the
shape variants found to be associated with hip OA is
unknown43,47e51. Thus, radiographs can be used to identify
morphological risk factors for OA and to deﬁne the disease in later
stages, but they are insensitive to deﬁne early hip OA.Fig. 4. (A): Pelvic radiograph. The right hip shows signs of mixed impingement, with
CAM (*) and pincer impingement (white arrowhead). There is no evidence of JSN seen
on radiograph but a rim fracture is noted. (B): A morphologic MRI with indirect
arthrography of the same diseased right hip, which shows labral chondral degenera-
tion (white arrowhead). (C): A dGEMRIC scan of this hip shows fairly extensive
acetabular cartilage damage as indicated by dark red and black regions in the
acetabular cartilage (area between two white arrowheads).MRI of articular cartilage
Conventional MRI is widely used for evaluation of the hip joint.
In contrast to hip radiography, hip MRI generates enough contrast
to detect morphological changes52 and several semi-quantitative
scoring systems have been developed in order to measure OA
progression from MR scans13,53. Additionally, diagnosis of labral
tears in FAI and hip dysplasia patients can be accurately done using
MRI and MR arthrography54,55. However, compared to arthroscopic
ﬁndings, the accuracy of MR based techniques for the diagnosis of
chondral lesions is rather limited56,57. Using conventional MRI, it
also is not possible to image changes related to sGAG loss from
cartilage ECM58. The use of delayed gadolinium enhanced MRI of
cartilage (dGEMRIC) was ﬁrst described by Bashir et al.59,60. It can
be considered a breakthrough in OA imaging, since from then on it
enabled measurement of cartilage sGAG loss in a quantitative
manner. The dGEMRIC method is now quite commonly used as a
tool for quantitative cartilage analysis59e61 in a reproducible
fashion62,63. In dGEMRIC, Gd(DTPA)2- is typically injected intrave-
nously and allowed to distribute into the articular joint of interest.
This is in contrast to hip MR-arthrography (MRA) where the
contrast agent is injected directly into the joint55,64. The dGEMRIC
technique does provide an indirect arthrogram for labral tear
detection without capsular distension. Conversely, some in-
vestigators have used a direct injection of contrast to get a directarthrographic effect as well as a dGEMRIC image in the hip65. This is
feasible in the hip due to the thin articular cartilage and hence a
rapid transport of contrast into cartilage from the articular side.
Due to ﬁxed sGAG within the articular ECM and the resulting FCD,
the negatively charged contrast agent is repulsed from the carti-
lage. As a consequence, when sGAGs are depleted from the cartilage
and Gd(DTPA)2- is able to accumulate within cartilage in an inverse
relationship to the sGAG content of the cartilage66 [Fig. 4]. Within
FAI patients, a marked reduction in sGAG content in hip cartilage
was seen using dGEMRIC compared to asymptomatic volunteers67,
which might be an index for OA in an early phase. More recently,
dGEMRIC proved to be accurate enough in detecting cartilage
damage in FAI patients, and is a highly reliable technique in terms
of intra- and inter-observer repeatability68.
Another MRI technique frequently used in OA hip evaluation is
T2 mapping69,70. This technique is thought to measure early
changes in articular cartilage collagen content and orientation,
which has been demonstrated in both in vitro71,72 and in vivo73,74
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demonstrated cartilage degeneration in patients with hip
dysplasia75 and slipped capital femoral epiphysis76. However, other
studies also showed a relationship between T2 mapping and
cartilage sGAG content77e79. Due to ongoing sGAG loss, the articular
cartilage collagen matrix is less equipped to absorb contact stresses
during physical activity and more prone for damage to the collagen
matrix. If collagen damage develops secondary to sGAG loss, this
might explain why T2 mapping also relates to cartilage sGAG con-
tent. It also suggest that T2 mapping might not be sensitive enough
for detection of early OA changes.
Besides dGEMRIC and T2 mapping, other techniques (e.g., so-
diumMRI, T1rho, and fast ﬁeld-cycling nuclear magnetic resonance
(NMR)80e82) and MR sequences (e.g., Ultrashort TE83, SSFP84, UTE
T2*85, CEST86 and DENSE-FSE87) have been developed for quanti-
tative measurements of articular cartilage quality. As for dGEMRIC
and T2 mapping, most of these techniques are still in need of
extensive validation in the general population before a general
clinical application can be considered.Computed tomography (CT) of subchondral bone and articular
cartilage
One of the main advantages of CT, is its ability for accurate im-
aging of (subchondral) bone. Müller-Gerbl et al. showed already in
the 90s that CT can provide a surface representation of the 3D
density distribution in joints of living subjects88. The distribution of
Hounsﬁeld density within subchondral bone represents the dis-
tribution of bone mineralization, and age-related changes in hip,
wrist and ankle joints have been reported. CT imaging showed
(qualitative) bone adaptation related to different levels of physical
activity with increased mineralization in gymnasts or reduced
mineralization due to postoperative immobilization. CT also proved
a suitable technique for noninvasive investigation of subchondral
bone changes within (OA) patients89.
Although CT is predominantly used for bone analysis in
musculoskeletal imaging, contrast enhanced CT arthrography (CTA)
can detect soft tissue injury. CTA using intra-articular injected
contrast agent is an established clinical technique for imaging of
hip90,91 and knee92,93 abnormalities. Compared to MRI or MRA, CT
has a better spatial resolution and higher contrast of signal between
adjacent joint tissues and synovial ﬂuid94e97. From cadaver studies,
we know that CTA of the hip allows for accurate assessment of
acetabular cartilage96,97. Recently, it was established that CTA is
able to measure sGAG content in large anatomical cartilage regionsFig. 5. Clinically applied CTA of a human knee joint. (A): Ex-vivo equilibrium partitioning of
patellar cartilage. (B): Patellar result of clinically applied CTA using different radiation doseof human cadaveric knee joints [Fig. 5]98. Although this study
focused on knee joints and future studies are needed in order to
validate these measurements for hip arthrography.
CTA does have all the features to become a valuable tool for
quantitative cartilage analysis in (hip) OA research. Of course, ra-
diation exposure is one of the major concerns regarding CT based
techniques and poses the major limitation for this technique99.
However, CTA using low radiation dose also measures cartilage
sGAG content100 and makes CT-based cartilage analysis clinically
feasible [Fig. 5]. Then again, CTA has short scanning times (~30 s),
generates images with high isotropic resolution, and CT is relatively
cheap. Further developing CT (detector) technology and newer
software will provide more detailed images, but with even lower
radiation exposure. These advances might fuel the development of
simultaneous analysis of articular cartilage together with sub-
chondral bone quality101. Another advantage of CT is that it
potentially allows to quantify morphological abnormalities, like in
FAI patients, in three dimensions102. Motion simulation based upon
these 3D CT scans possibly provides a dynamic approach to eval-
uate the location of bony impingement, thereby taking into account
other important variables such as femoral and acetabular orienta-
tion103. However, these techniques are not yet thoroughly validated
and their additional value in the prediction of hip OA remains un-
known. In summary, the possibility to identify predisposing factors
(cam impingement, dysplasia) and to quantify early signs of OA
(subchondral bone changes, cartilage quality) makes CT evaluation
in OA more and more exciting.Emerging modalities for early OA imaging: SPECT and PET
With CT, it is only possible to visualize the amount and location
of periarticular bone formation that has resulted from enhanced
bone remodelling. However, using single photon emission
computed tomography (SPECT) scanning, it is possible to visualize
the amount and location of bone turnover and capture actual ac-
tivity that leads to bone formation seen only afterwards with CT
[Fig. 6(A)e(C)]. The general procedure involves an intravenous in-
jection with 99mTechnetium-methylene diphosphonate (99mTc-
MDP), which will be incorporated into the hydroxyapatite of
exposed osteoid at sites of bone formation and destruction. Sub-
sequently the radioactive signal is traced in the SPECT scanner. In
clinics, SPECT scanning using radioactive labelled poly-
phosphonates already proved to be highly sensitive for detecting
and monitoring OA104e106. It correlates with osteophytes on ra-
diographs107, meniscus injury108,109, osteochondral lesions110,an ionic contrast agent using (EPIC-)microCT as a reference test for sGAG distribution of
s. The maximal radiation dose applied was 81.33 mGy per scan.
Fig. 6. A SPECT/CT scan of patient with evident pincer impingement injected with 99mTc-MDP. (A): Coronal image of the pelvic area with clear sign of a pincer deformity (red
arrowhead). (B): Bone scintigraphy shows clear uptake of radioactive 99mTc-MDP on the lateral acetabular border. (C): Combined SPECT/CT image shows clear 99mTc-MDP uptake
within the pincer deformity. (D): 99mTc-MDP microSPECT/CT scan of a rat knee 24 h after mono-iodoacetate induced OA. Compared to the contralateral healthy control joint (green
striped box), the OA induced knee joint (red striped box) shows a clear increase of 99mTc-MDP uptake within the femoral condyles. All activity outside both striped boxes are due to
bone remodelling within epiphyseal growth plate of the rat, in these animals the growth plate never closes.
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MRI ﬁndings of bone marrow lesions (BML) showed a nice agree-
ment with increased radioactive uptake in bone scintigraphy112,113.
In one of our pre-clinical studies using an animal OAmodel, as early
as 48 h after injection of iodoacetate in a rat joint leading to
cartilage deterioration, we found signiﬁcant alterations in the
subchondral bone [Fig. 6(D)]. This suggests that early OA changes
happen within the osteochondral subunit, which can be measured
accurately with SPECT/CT.
Another interesting technique using SPECT/CT, measures
macrophage activationwithin the synovium. Secondary to cartilage
damage, episodes of (chronic) inﬂammation is known to develop
within the synovium8. During this inﬂammatory response, mac-
rophages inﬁltrate the synovium and become activated114. The
synovium becomes a source of proinﬂammatory and catabolic
products that stimulate neo-angiogenesis, synovial hyperplasia and
ﬁbrosis115. Especially, the activated macrophages are thought to
produce cytokines and growth factors such as TGFb, BMP-2, BMP-4,
known to induce osteophytosis and synovial ﬁbrosis116,117. Inter-
estingly, activated macrophages express the functional form of
folate receptor b (FRb)118. This receptor is absent in quiescent
macrophages and other immune cells, rendering FRb a very suitable
target for molecular imaging. The vitamin folic acid binds with high
afﬁnity to FRb. After injecting a diagnostic radioactive coupled to a
folic acid analogue, the presence of the FRb can be traced with high
sensitivity using nuclear imaging techniques such as SPECT or
positron emission tomography (PET). This technique has demon-
strated elevated levels of activated macrophages in both rheuma-
toid arthritis as well as OA animal models114. When applied in a
mild and severe OA rat model, therewasmore FRb related uptake in
the severe model compared to the mild OA model [Fig. 7]119.
Interestingly, there was also more osteophyte formation in the
severe OA model [Fig. 7]. When this technique can be applied in
clinical practice, this might seriously enhance our ability to predict
degenerative changes at much earlier disease stages of OA.
Discussion
The term early OA is gaining much attention in the OA literature,
with the idea that earlier detection might give better options for
treatment. This is a very reasonable assumption since a completely
deteriorated hip or knee would require not only cartilage regen-
eration, but a drastic restoration of the deformed bone as well. An
abnormal hip shape or incongruity of the hip joint is one of the best
known triggers that induces hip OA. In fact, hip OA resulting from
an abnormal hip shape might be considered as one speciﬁc type of
(hip) OA. Several speciﬁc shape variants have been identiﬁed that
can be clearly differentiated from a normal (average) hip shape,such as dysplasia or cam deformity. However, we suspect more
non-optimal hip shape forms and probably mixed variants that are
deleterious for a life-time support of load bearing and low friction.
Already more subtle shape variants have been found to be
associated with OA with new techniques that quantify hip shape
(like SSM)46,49,120. Some of these subtle shape variants are difﬁcult
to interpret and either may be an early sign of OA or a predisposing
factor. Since not all individuals with these shape aspects develop
OA, other systemic or environmental factors such as heavy physical
workload or high impact sporting activities are needed to really
drive the hip towards OA. In other words, many people with an
‘abnormal’ hip shape variant will not develop hip OA unless they
have other risk factors as well. Obviously, also the genetic back-
ground of an individual contributes to the possibility if a personwill
develop OA or not. This is not surprising as genes have an effect on
bone shape as well. However, things can also be more complicated.
Recently, the DIO2 SNP was associated with hip OA121 and shape
analysis showed that some shape variants of the hip were more
associated with hip OA in carriers of the DIO2 SNP49. These studies
teach us that where hip OA might predominantly be caused by
biomechanical factors as a result of an abnormal hip shape or in-
congruity, other (systemic) factors might positively or negatively
modify this relationship.
Due to our improved understanding of the role of hip
morphology on the future risk of hip OA, surgeons often treat a cam
deformity by arthroscopic removal. Up to ~25% of the adult male
population have a cam deformity that may predispose the hip to OA
and at present, approximately 60,000 hip arthroscopy cases are
performed in the United States, which is growing at ~15% per year.
While being a relatively mild operative procedure, it is still an
invasive treatment and appropriate patient selection is a prereq-
uisite for justifying such a surgery. Previous clinical studies suggest
that successful cam removal is dictated by the extent of already
existing damage in the joint122e125. Hence, more detailed (multi-
modality) imaging might be able to more accurately select patients
who might beneﬁt from surgical cam removal well before articular
cartilage is structurally compromised. Furthermore, long-term
consequences of surgical correction of a cam on the progression
of OA is yet unknown. In order to address these issues, a more
sensitive imaging marker of OA is necessary. Some even argue that
lack of an imaging technique sensitive for (early) OA changes, is the
major impediment to development and successful implementation
of new disease modifying (surgical) therapies.
New imaging techniques like advanced MRI techniques and
molecular imaging techniques are emerging and might contribute
to solving these issues. However, these techniques have not yet
maturated enough in order to give us reliable answers to the
questions at hand. This is mostly due to the simple fact, that the
Fig. 7. Sagittal SPECT/CT images of knee joints that show macrophage activation through binding of 111In-DOTA-Bz-folate. CT images shown in black and white were used for
anatomical reference, the SPECT images are shown in colour. Transaxial images from patellar bone extracted from binary mCT images show ectopic bone formation (red colour). With
increasing severity of experimentally induced OA the level of macrophage activation increases, as well as an increase of ectopic bone formation can be seen.
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open population studies. Then again, applying new imaging tech-
niques in a large open population study immediately raises other
issues. Nowadays, there are no clear deﬁnitions for morphologic
variations of the hip that associate with hip OA. Can we deﬁne an
average morphology and subsequently deﬁne for each individual
the deviation from the average? Statistical shapemodels provide us
the tools to do this. But how big of a deviation is considered normal
and where does pathology start?
Another concern is that the disease process might change the
morphology of the tissue. For example the shape of the bone can
clearly change as a consequence of OA, but there is also shape
variation independent of the OA process. Where the ﬁrst is more an
indicator of the disease, the latter is considered a predisposing risk
factor and might be more or less related to the individual genetics
and/or activity level. However, the indicator might also contribute
to the disease progression as it can impair femoral head sphericity
and as a consequence harm comfortable biomechanical load
transfer.
The same holds true for the status of cartilage tissue, whether
sGAG loss is a valid sign of early OA is not entirely known. Some
individuals might have relatively lower sGAG levels without lead-
ing to any clinical problems. Of course this might be related to
genetics, but it might also be related to the natural activity level of
the individual. Production of sGAG might also be dependent on
mechanical loading126 and maybe a low amount can easily be
restored if all other aspects of the cartilage are physiologically
normal. So the question is: is a low amount of sGAG a risk factor for
OA, or already a very early sign of a mild stage of the OA process?
Quantitative analysis of cartilage using dGEMRIC have not provided
us with a clear answer yet.
New diagnostic imaging techniques like SPECT/CT and PET are
likely to be more widely implemented in the next decade for
clinical OA care and research. These techniques might provide us
with more knowledge on different OA subtypes, their interaction
with different joint tissues and map OA changes on a molecular
level. We believe that knowledge derived using these techniques,
will enable us to generate new DMOADs and divert intervention
techniques away from costly and invasive (arthroscopic) surgery.
However, similar to shape or morphology analysis and quantitativeanalysis of cartilage using MRI, we have no clear concept of the
normal distribution of these new variables within the general
population and whether a change in signal indicates relevant pa-
thology remains unclear. Nor do we know what the clinical
meaning is of a speciﬁc variation from average. Therefore, it would
be meaningful to generate reference data with normal ranges of
such variation.
In other words, one cannot identify sickness when blind for
health.
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